Researchers Develop Dual-Target CRISPR Strategy to Improve Cystic Fibrosis Gene Therapy in Pig Cells
Scientists tested a new CRISPR/Cas9 approach that targets two genomic locations simultaneously to improve the integration of a functional CFTR gene into cells, achieving integration rates of 3.4% for the therapeutic gene in porcine epithelial cells. The method addresses a major limitation of previous gene therapy attempts: the low efficiency of the cell's natural DNA repair pathway (HDR) in incorporating replacement genes. The findings suggest a potential pathway toward more effective gene therapy treatments for cystic fibrosis lung disease.
Researchers at bioRxiv published findings on a dual-locus-targeting CRISPR/Cas9 strategy designed to enhance gene replacement therapy for cystic fibrosis. The study used helper-dependent adenoviral vectors to deliver the gene-editing system into porcine epithelial cells, targeting both the CFTR gene (the defective gene in CF) and a genomic safe harbor site called GGTA1. By sequentially delivering two vectors, the team achieved integration efficiency of 3.4% for the CFTR donor gene, a meaningful improvement over previous single-target approaches. The core challenge the research addresses is that homology-directed repair (HDR)—the cell's mechanism for incorporating new genetic material—occurs infrequently, limiting the effectiveness of standard CRISPR-based gene replacement. The dual-locus approach appears to circumvent this bottleneck, though the work remains in the preclinical stage using animal cell models.
What's missing
The study's limitations include: testing was conducted only in porcine epithelial cells in vitro, not in living animals or human cells; the 3.4% integration rate, while improved, remains relatively low for clinical application; long-term expression stability and potential off-target effects of the dual-vector approach are not discussed; and the pathway from this proof-of-concept to human clinical trials is unclear.
What different sources said
- bioRxivCenter
A Dual-Locus-Targeting Strategy to Enhance CRISPR/Cas9-mediated CFTR Replacement via Helper-Dependent Adenoviral vector in porcine genome
Related
Topology-Aware Thermodynamics Improves DNA Probe Specificity Design
Researchers developed a new framework for designing DNA probes that accounts for the spatial organization of matched sequences, not just overall thermodynamic stability. Traditional methods rely on scalar measures like melting temperature and free energy, which miss how mismatches are distributed along the probe. The approach could improve diagnostic accuracy in applications like HPV detection and gene expression profiling.
Study Identifies Optimal Thermal Dose for Combining Focused Ultrasound with Immunotherapy in Tumors
Researchers used multimodal PET imaging to identify an optimal thermal dose range for focused ultrasound ablation that destroys tumor tissue while preserving conditions for immunotherapy delivery. The study found that excessive heating collapses blood vessels needed for antibody access, while insufficient heating fails to adequately reduce tumor burden. The findings could guide clinical design of combination treatments pairing thermal ablation with immunotherapies.
Plant MSH1 Protein Functions as Mismatch-Directed Nuclease for Organelle Genome Maintenance
Researchers have identified the precise mechanism by which the AtMSH1 protein in Arabidopsis plants recognizes and cleaves DNA mismatches and lesions, preventing mutations in organellar genomes. The protein combines a DNA mismatch recognition module with a nuclease domain that makes staggered cuts at specific positions relative to DNA damage. This discovery explains how plants maintain unusually low mutation rates in their mitochondrial and chloroplast DNA compared to other eukaryotes.